Nichols Weston has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 6900 shares of Crinetics Pharmaceuticals, Inc. ($CRNX) on June 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Not found | A | Common Stock | 6900 | $0.00 | 16,300.0000 | 92,926,000 | 73.40% | 0.01% |
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Not found | A | Common Stock | 3400 | $0.00 | 9,400.0000 | 68,175,000 | 56.67% | 0.00% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Director | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Nichols Weston | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |